Image
|
Figure Caption
Fig. 6 Trap230 is required as a coactivator for Sox9. (A, C, E, G, I, K, M, O) WT embryos. (B, D, F, H, J, L, N, P) tpd mutants. Embryos are at the 3-somite stage, dorsal view, anterior to the left. (A–D) foxd3 expression. (E–H, K, L) snai1b Expression. (I, J) Sox10 expression. (M–P) six3 expression. (C, G) WT embryo injected with Sox9b mRNA; (D, H) tpd mutant injected with Sox9b mRNA. (K) WT embryo injected with Sox9b-VP16 mRNA; (L) tpd mutant injected with Sox9b-VP16 mRNA. (O) WT embryo injected with prdm1 mRNA. (P) tpd mutant injected with prdm1 mRNA.
Figure Data
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Reprinted from Developmental Biology, 296(1), Rau, M.J., Fischer, S., and Neumann, C.J., Zebrafish Trap230/Med12 is required as a coactivator for Sox9-dependent neural crest, cartilage and ear development, 83-93, Copyright (2006) with permission from Elsevier. Full text @ Dev. Biol.